Express News | Nanovibronix: on April 10, Got Nasdaq Letter That Co Did Not Meet Minimum Bid Price Required for Continued Listing on the Nasdaq Capital Market

Moomoo 24/7Apr 15 16:07 ET

NanoVibronix Inc Highlights 2023 Performance and Updates

TipRanksApr 9 16:24 ET

Express News | NanoVibronix Q4 2023 Revenue ~$1.2M

Moomoo 24/7Apr 9 08:56 ET

NanoVibronix Issues Letter To Stockholders

We are committed to our strategic vision of developing, improving and commercializing our distinct and effective therapies, which we believe enable healthcare providers to treat patients in need, fill

BenzingaApr 9 08:55 ET

NanoVibronix Enhances Products With Veranex Partnership

TipRanksMar 28 09:22 ET

NanoVibronix Signs Agreement For Research And Development Of Next Generation PainShield And UroShield

Efforts Focused on Adding Therapeutic Functionality and Reducing CostsNanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical device company that produces the UroShield, PainShie

BenzingaMar 28 08:36 ET